Aspiriant LLC’s Schwab International Equity ETF SCHF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Buy
37,458
+867
+2% +$23.4K 0.03% 170
2026
Q1
$906K Buy
36,591
+4,958
+16% +$126K 0.03% 162
2025
Q4
$760K Buy
31,633
+4,307
+16% +$102K 0.02% 177
2025
Q3
$636K Buy
+27,326
New +$617K 0.02% 184
2024
Q3
Sell
-19,430
Closed -$373K 307
2024
Q2
$373K Buy
+19,430
New +$376K 0.02% 208
2021
Q4
Sell
-10,482
Closed -$203K 284
2021
Q3
$203K Sell
10,482
-1,404
-12% -$27.9K 0.01% 228
2021
Q2
$235K Buy
+11,886
New +$235K 0.01% 217
2018
Q4
Sell
-19,712
Closed -$331K 249
2018
Q3
$331K Buy
+19,712
New +$328K 0.03% 185

Other funds holding SCHF

Aspiriant LLC's SCHF Position: Q2 2026 in Review

Aspiriant LLC increased its Schwab International Equity ETF (SCHF) stake by 2.4% in Q2 2026, buying an estimated $23.4K and bringing the position to 37,458 shares worth $1.04M. The position accounts for 0.03% of the portfolio, ranked #170.

Aspiriant LLC first reported a position in SCHF in Q3 2018 and has held it in 8 quarters since. 1,660 funds tracked by Wall St. Rank hold SCHF as of Q2 2026.

  • Aspiriant LLC held 37,458 shares of Schwab International Equity ETF worth $1.04M as of Q2 2026.
  • Aspiriant LLC bought 867 Schwab International Equity ETF shares in Q2 2026, an estimated $23.4K.
  • Schwab International Equity ETF made up 0.03% of Aspiriant LLC's portfolio in Q2 2026, its #170 holding.
  • Aspiriant LLC first reported a position in Schwab International Equity ETF in Q3 2018 and has held it in 8 quarters since.
  • 1,660 funds tracked by Wall St. Rank held Schwab International Equity ETF as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.